Home Tags CBD
CBD Related Content
In this final article of a series of five, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine when it comes to treating COVID-19.
Here, OilsBySimpson explains the findings of a new study on 400 patients prescribed cannabidiol (CBD). The results show promise for pain, anxiety, and depression.
Christian Hendriksen, VP of International Expansion at Mile High Labs, illustrates how they are continuing compliance with the novel food application to ensure safe and effective cannabinoids can be available to all.
Here, Josh Smith talks us through the current pandemic and the recent history underlying the fight for legalising medical cannabis.
Here, OilsBySimpson Founder Kevin William Simpson, explains what current research shows about CBD’s effect on epilepsy and its applications as a treatment.
Canna CBD Limited shares with us 12 ways you can take cannabidiol (CBD), including oils, tinctures, pills, edibles, as well as products for localised relief like bath salts, lotions, roll-ons and creams.
John Binns, Partner at BCL Solicitors LLP, provides us with fresh insight into COVID-19 and medical cannabis. He ponders if the crisis could bring opportunities for the industry.
Here, Robert Thomas, Principal Consultant, Scientific Solutions, highlights the importance of measuring metals in cannabis and hemp.
A worldwide manufacturer and distributor of cannabinoid products, Elixinol are committed to creating the best organic hemp products for the mass market.
Vatra Syla, Head of Marketing, Storz & Bickel GmbH & Co. KG, discusses the importance of medical cannabis vaporizers.
Here, European Union (EU) Novel Food regulations are thoroughly explored and questioned in the context of CBD in food.
Here, we discuss how unregulated industry patient advocates are integral to strengthening the credibility of growing CBD brands.
In this North America April 2020 edition, David Goff at the National Heart, Lung, and Blood Institute, details the support for heart and vascular health research.
Michael A. Rogers outlines four necessary elements to increase further societal understanding about the use of cannabis edibles.
CEO of OC Care ApS, Christian Ohlendorff Hollensen, illuminates us on what we need to know about the cultivation of sustainable and organic medical cannabis in controlled environments, including the essential factor of lighting.
Speaking with Sarah Yetman, CEO of Sovereignport, we understand how she pioneered a CBD and hemp supply chain that is surviving COVID-19 measures.
Here, Hassan Akhtar explains how Cannyx Markets UK Ltd. Are successfully navigating the globalisation of the CBD industry.
Delve into the story of Kevin Simpson, who used Cannabidiol (CBD) to treat Type 2 Diabetes.
We spoke to Professor Mike Barnes, to discuss the future of medical cannabis and cut through the fake news saturating the field.
At Mile High Labs, we share a collective vision for global standards of CBD quality and compliance: Let’s discuss the Novel Food application process for the UK.